Anticancer Drugs Olaparib Oncology Pharmacology Physiotherapy

Olaparib (Drug Interaction-1)

In this article we will discuss Olaparib (Drug Interaction-1)

In this article, we will discuss Olaparib (Drug Interaction-1). So, let’s get started.

Use with Anticancer Agents
Clinical studies of Olaparib with other myelosuppressive anticancer agents, including DNA damaging agents, indicate a potentiation and prolongation of myelosuppressive toxicity.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.